Pharmacologic treatment of essential tremor

Neurology

Volumn 54, Issue 11 SUPPL. 4, 2000, Pages

  Koller, William C ^a   Hristova, Anna ^b   Brin, Mitchell ^c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOTULINUM TOXIN A; CARBONATE DEHYDRATASE INHIBITOR; CLONIDINE; CLOZAPINE; FLUNARIZINE; GABAPENTIN; METHAZOLAMIDE; METHYLXANTHINE DERIVATIVE; NIMODIPINE; PRIMIDONE; PROPRANOLOL; THEOPHYLLINE;

ADULT; AGED; ARTICLE; ASTHENIA; ATAXIA; DISABILITY; DROWSINESS; DRUG EFFICACY; ESSENTIAL TREMOR; FUNCTIONAL DISEASE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MOTOR DYSFUNCTION; PRIORITY JOURNAL; VERTIGO;

AGED; ANTICONVULSANTS; BOTULINUM TOXIN TYPE A; CLINICAL TRIALS; ESSENTIAL TREMOR; HUMANS; MIDDLE AGED; NEUROMUSCULAR AGENTS; PRIMIDONE;

EID: 0034643902     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (94)

1. Koller WC, Busenbark KL. Essential tremor. In: Watts RL, Koller WC, eds. Movement Disorders: Neurologic Principles and Practice. New York: McGraw-Hill, 1997;365-385.
2. Elble R, Koller WC. The diagnosis and pathophysiology of essential tremor. In: Elble R, Koller WC, eds. Tremor. Baltimore: John Hopkins University Press, 1990:1-204.
3. Sasso E, Perucca E, Fava R, Calzetti S. Quantitative comparison of barbiturates in essential hand and head tremor. Mov Disord 1991;6:65-68.
4. Sasso E, Perucca E, Fava R, Calzetti S. Primidone in the long-term treatment of essential tremor: a prospective study with computerized quantitative analysis. Clin Neuropharmacol 1990;13:67-76.
5. Sasso E, Perucca E, Calzetti S. Double-blind comparison of primidone and phenobarbital in essential tremor. Neurology 1988;38:808-810.
6. Dietrichson P, Espen E. Primidone and propranolol in essential tremor: a study based on quantitative tremor recording and plasma anticonvulsant levels. Acta Neurol Scand 1987;75: 332-340.
7. Gorman WP, Cooper R, Pocock P, Campbell MJ. A comparison of primidone, propranolol, and placebo in essential tremor, using quantitative analysis. J Neurol Neurosurg Psychiatry 1986;49:64-68.
8. Koller WC, Royse LV. Efficacy of primidone in essential tremor. Neurology 1986;36:121-124.
9. Findley LJ, Cleeves L, Calzetti S. Primidone in essential tremor of the hands and head: a double blind controlled clinical study. J Neurol Neurosurg Psychiatry 1985;48:911-915.
10. Findley LJ, Calzetti S. Double-blind controlled study of primidone in essential tremor: preliminary results. BMJ 1982;285: 608-612.
11. Koller WC, Busenbark K, Miner K. The relationship of essential tremor to other movement disorders: report on 678 patients. Essential Tremor Study Group. Ann Neurol 1994;35: 717-723.
12. Porter RM. Report on the effects of introducing primidone for essential tremor [Letter]. Med J Aust 1992;157:840,842.
13. Koller WC, Busenbark K, Gray C, Hassanein RS, Dubinsky R. Classification of essential tremor. Clin Neuropharmacol 1992; 15:81-87.
14. Lou JS, Jancovic J. Essential tremor: clinical correlates in 350 patients [see Comments]. Neurology 1992;42:1432-1434.
15. Koller WC, Vetere-Overfield B. Acute and chronic effects of propranolol and primidone in essential tremor. Neurology 1989;39:1587-1588.
16. Herskovits E, Figueroa A, Mangone C. Hereditary essential tremor in Buenos Aires (Argentina). Arq Neuropsiquiatr 1988; 46:238-247.
17. Seyfert S, Hone A, Holl G. Primidone and essential tremor. J Neurol 1988;235:168-170.
18. Biary N, Koller WC. Essential tongue tremor. Mov Disord 1987;2:25-29.
19. Crystal HA. Duration of effectiveness of primidone in essential tremor. Neurology 1986;36:1543.
20. Koller WC, Royse VL. Efficacy of primidone in essential tremor. Neurology 1986;36:121-124.
21. Hartman DE, Vishwanat B. Spastic dysphonia and essential (voice) tremor treated with primidone. Arch Otolaryngol 1984; 110:394-397.
22. Chakrabarti A, Pearce JM. Essential tremor: response to primidone [Letter]. J Neurol Neurosurg Psychiatry 1981;44: 650.
23. Clazetti S, Findley LJ, Pisani F. Phenylethylmalonamide in essential tremor: a double-blind controlled study. J Neurol Neurosurg Psychiatry 1981;44:932-934.
24. Caccia MR, Osio M, Gelimberti V, Cataldi G, Mangoni A. Propranolol, clonidine, urapidil and trazodone infusion in essential tremor: a double-blind crossover trial. Acta Neurol Scand 1989;79:379-383.
25. Cleeves L, Findley L. Propranolol and propranolol-LA in essential tremor: a double blind comparative study. J Neurol Neurosurg Psychiatry 1988;51:379-384.
26. Teravainen H, Huttunen J, Larsen TA. Selective adrenergic beta-2-receptor blocking drug, ICI-118.551, is effective in essential tremor. Acta Neurol Scand 1986;74:34-37.
27. Cleeves L, Findley LJ. Beta-adrenoreceptor mechanisms in essential tremor: a comparative single dose study of the effect of a non-selective and a beta-2-selective adrenoreceptor antagonist. J Neurol Neurosurg Psychiatry 1984;47:976-982.
28. Findley LJ, Cleeves L. Beta adrenoreceptor antagonists in essential tremor. Lancet 1984;1:856-857.
29. Baruzzi A, Procaccianti G, Martinelli P, et al. Phenobarbital and propranolol in essential tremor: a double-blind controlled clinical trial. Neurology 1983;33:296-300.
30. Calzetti S, Findley LJ, Perucca E, Richens A. The response of essential tremor to propranolol: evaluation of clinical variables governing its efficacy on prolonged administration. J Neurol Neurosurg Psychiatry 1983;46:393-398.
31. Larsen TA, Teravainen H, Calne DB. Atenolol vs. propranolol in essential tremor. A controlled, quantitative study. Acta Neurol Scand 1982;66:547-554.
32. Calzetti S, Findley LJ, Perucca E, Richens A. Controlled study of metoprolol and propranolol during prolonged administration in patients with essential tremor. J Neurol Neurosurg Psychiatry 1982;45:893-897.
33. Calzetti S, Findley LJ, Gresty MA, Perucca E, Richens A. Metoprolol and propranolol in essential tremor: a double-blind, controlled study. J Neurol Neurosurg Psychiatry 1981; 44:814-819.
34. Findley LJ, Calzetti S, Gresty MA, Paul EA. Amplitude of benign essential tremor and response to propranolol. Lancet 1981;2:479-480.
35. Jefferson D, Jenner P, Marsden CD. Beta-adrenoreceptor antagonists in essential tremor. J Neurol Neurosurg Psychiatry 1979;42:904-909.
36. Teravainen H, Fogelholm R, Larsen A. Effect of propranolol on essential tremor. Neurology 1976;26:27-30.
37. Tolosa ES, Loewenson RB. Essential tremor: treatment with propranolol. Neurology 1975;25:1041-1044.
38. Schwartz K, Jankovic J. Botulinum treatment of tremors. Neurology 1991;41:1185-1188.
39. Jankovic J, Schwartz K, Clemence W, Aswad A, Mordaunt J. A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type a in essential hand tremor. Mov Disord 1996;11:250-256.
40. Trosch RM, Pullman SL. Botulinum toxin A injections for the treatment of hand tremors. Mov Disord 1994;9:601-609.
41. Henderson JM, Ghika JA, Van Melle G, Haller E, Einstein R. Botulinum toxin A in non-dystonic tremors. Eur Neurol 1996; 36:29-35.
42. Wissel J, Masuhr F, Schelosky L, Ebersbach G, Poewe W. Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor. Mov Disord 1997;12:722-726.
43. Tsui JKC, Eisen A, Stoessl AJ, Calne S, Calne DB. Double-blind study of botulinum toxin in spasmodic torticollis. Lancet 1986;2:245-247.
44. Finsterer J, Muellbacher W, Mamoli B. Yes/yes head tremor without appendicular tremor after bilateral cerebellar infarction. J Neurol Sci 1996;139:242-245.
45. Brown JR, Simonson J. Organic voice tremor: a tremor of phonation. Neurology 1963;13:520-525.
46. Meeuwis CA, Baarsma EA. Essential (voice) tremor. Clin Otolaryngol 1985;10:54-58.
47. Findley L, Gresty M. Head facial and voice tremor. Adv Neurol 1988;49:239-253.
48. Aronson AE. Clinical Voice Disorders. New York: Thieme, 1985.
49. Lebrun Y, Devreux F, Rousseau JJ, Darimont P. Tremulous speech. A case report. Folia Phoniatr (Basel) 1982;34:134-142.
50. Ludlow C, Bassich C, Connor N, Coulter D. Phonatory characteristics of vocal fold tremor. J Phon 1986;14:509-515.
51. Brin MF, Blitzer A, Stewart C. Vocal tremor. In: Findley LJ, Koller WC, eds. Handbook of Tremor Disorders. New York: Marcel Dekker, 1995:495-520.
52. Brin MF, Blitzer A, Fahn S, Gould W, Lovelace RE. Adductor laryngeal dystonia (spastic dysphonia): treatment with local injections of botulinum toxin (Botox). Mov Disord 1989;4:287-296.
53. Blitzer A, Brin M. Laryngeal dystonia: a series with botulinum toxin therapy. Ann Otol Rhinol Laryngol 1991;100:85-89.
54. Ludlow CL. Treating the spasmodic dysphonias with botulinum toxin: a comparison with adductor and abductor spasmodic dysphonia and vocal tremor. In: Tsui JKC, Calne DB, eds. Handbook of Dystonia. New York: Marcel Dekker, 1995; 431-446.
55. Stager SV, Ludlow CL. Responses of stutterers and vocal tremor patients to treatment with botulinum toxin. In: Jankovic J, Hallett M, eds. Therapy with Botulinum Toxin. New York: Marcel Dekker, 1994:481-490.
56. Guillain G, Mollaret P, Rees A, Maiwand OH, Garland MH. Deux cas de myoclonies synchrones et rythmées velopharyngo-laryngo-oculo-diaphragmatiques. Le probleme anatomizue et physiopathologique de çe syndrome. Rev Neurol 1931;II:545-566.
57. Lapresle J, Ben Hamida M. The dentato-olivary pathway. Somatotopic relationship between the dentate nucleus and the contralateral inferior olive. Arch Neurol 1970;22:135-143.
58. Guillain G. The syndrome of synchronous and rhythmic palatopharyngo-laryngo-oculo-diaphragmatic myoclonus. Proc R Soc Med 1938;31:1031-1038.
59. Lapresle and Ben Hamida 1970 ID: 5036.
60. Dubinsky RM, Hallett M. Palatal myoclonus and facial involvement in other types of myoclonus. Adv Neurol 1988;49: 263-278.
61. Jacobs L, Newman RP, Bozian D. Disappearing palatal myoclonus. Neurology 1981;31:748-751.
62. A. Politzer. Klonischer Krampf der Muskeln der Tuba Eustachii. Wien Med Presse 1870;11:561-562.
63. Deuschl G, Lohle E, Heinen F, Lucking C. Ear click in palatal tremor: its origin and treatment with botulinum toxin. Neurology 1991;41:1677-1679.
64. Deuschl G, Lohle E, Toro C, Hallett M, Lebovics RS. Botulinum toxin treatment of palatal tremor (myoclonus). In: Jankovic J, Hallett M, eds. Therapy with Botulinum Toxin. New York: Marcel Dekker, 1994:567-576.
65. Le Pajolec C, Marion MH, Bobin S. Objective tinnitus and palatal myoclonus. A new therapeutic approach. Ann Otolaryngol Chir Cervicofac 1990;107:363-365.
66. Casselbrant ML, Cantekin EI, Dirkmaat DC, Doyle WJ, Blue-stone CD. Experimental paralysis of tensor veli palatini muscle. Acta Otolaryngol (Stockh) 1988;106:178-185.
67. Rajput AH, Jamieson H, Hirsh S, Quraishi A. Relative efficacy of alcohol and propranolol in action tremor. Can J Neurol Sei 1975;2:31-35.
68. Koller WC, Biary N. Effect of alcohol on tremors: comparison with propranolol. Neurology 1984;34:221-222.
69. Teravainen H, Huttenen J, Lewitt P. Ineffective treatment of essential tremor with an alcohol, methylpentynol. J Neurol Neurosurg Psychiatry 1986;49:198-199.
70. Schroeder D, Nasrallah HA. High alcoholism rate in patients with essential tremor. Am J Psychiatry 1982;139:1471-1473.
71. Koller WC. Alcoholism in essential tremor. Neurology 1983; 33:1074-1076.
72. Rautakorpi I, Marttila RJ, Rinne UK. Alcohol consumption of patients with essential tremor. Acta Neurol Scand 1983;68: 177-179.
73. Boecker H, Wills AJ, Ceballos-Baumann A, et al. The effect of ethanol on alcohol-responsive essential tremor: a positron emission tomography study. Ann Neurol 1996;39:650-658.
74. Thompson C, Lang A, Parkes DJ, Marsden CD. A double-blind trial of clonazepam in benign essential tremor. Clin Neuropharmacol 1984;7:83-88.
75. Huber SJ, Paulson GW. Efficacy of alprazolam for essential tremor. Neurology 1988;38:241-243.
76. Burrows GT, King RB. Gabapentin in essential tremor [Abstract]. Neurology 1995;45(suppl 4):A187-188.
77. Adler CH. Effectiveness of gabapentin in various movement disorders [Abstract]. Mov Disord 1996;11(suppl 1):251.
78. Pahwa R, Lyons K, Hubble JP, et al. Double-blind controlled trial of gabapentin in essential tremor. Mov Disord 1998; 13: 465-467.
79. Muenter MD, Daube JR, Caviness JN, Miller PM. Treatment of essential tremor with methazolamide [see Comments]. Mayo Clin Proc 1991;66:991-997.
80. Busenbark K, Pahwa R, Hubble J, Hopfensperger K, Koller W, Pogrebra K. Double-blind controlled study of methazolamide in the treatment of essential tremor, [published erratum appears in Neurology 1993;43:1910]. Neurology 1993;43: 1045-1047.
81. Busenbark K, Ramig L, Dromey C, Koller W. Methazolamide for essential voice tremor. Neurology 1996;47:1331-1332.
82. Pakkenberg H, Pakkenberg B. Clozapine in the treatment of tremor. Acta Neurol Scand 1986;73:295-297.
83. Factor SA, Friedman JH. The emerging role of clozapine in the treatment of movement disorders. Mov Disord 1997;12: 483-496.
84. McCarthy RH. Clozapine reduces essential tremor independent of its antipsychotic effect: a case report [Letter]. J Clin Psychopharmacol 1994;14:212-213.
85. Biary N, al Deeb SM, Langenberg P. The effect of flunarizine on essential tremor. Neurology 1991;41:311-312.
86. Curran T, Lang AE. Flunarizine in essential tremor. Clin Neuropharmacol 1993;16:460-463.
87. Biary N, Bahou Y, Sofi MA, Thomas W, al Deeb SM. The effect of nimodipine on essential tremor. Neurology 1995;45: 1523-1525.
88. Topaktas S, Onur R, Dalkara T. Calcium channel blockers and essential tremor. Eur Neurol 1987;27:114-119.
89. Caccia MR, Mangoni A. Clonidine in essential tremor: preliminary observations from an open trial. J Neurol 1985;232:55-57.
90. Serrano Duenas M. Acute pharmacological test of clonidine in essential tremor, [in Spanish] Neurologia 1997;12:9-11.
91. Koller WC, Herbster G, Cone S. Clonidine in the treatment of essential tremor. Mov Disord 1986;1:235-237.
92. Buss DC, Marshall RW, Milligan N, McQueen I, Compston DA, Routledge PA. The effect of intravenous aminophylline on essential tremor. Br J Clin Pharmacol 1997;43:119-121.
93. Mally J, Stone TW. The effect of theophyllin on essential tremor: the possible role of GABA. Pharmacol Biochem Behav 1991;39:345-349.
94. Mally J, Stone TW. Efficacy of an adenosine antagonist, theophylline, in essential tremor: comparison with placebo and propranolol. J Neurol Sci 1995;132:129-132.